XML 44 R29.htm IDEA: XBRL DOCUMENT v3.7.0.1
Quarterly Financial Information (unaudited)
 12 Months Ended
Dec. 31, 2016
Quarterly Financial Information (unaudited) [Abstract]  
Quarterly Financial Information (unaudited)
20.
Quarterly Financial Information (unaudited)

(In thousands, except per share data)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Year Ended December 31, 2016
 
 
First
 
 
Second
 
 
Third
 
 
Fourth (3)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenues
 
 
$
126,012
 
 
$
125,003
 
 
$
125,049
 
 
$
124,933
 
Gross margin
 
 
$
33,105
 
 
$
34,590
 
 
$
34,562
 
 
$
38,304
 
Income before income taxes
 
 
$
19,208
 
 
$
19,962
 
 
$
17,925
 
 
$
20,972
 
Net income from continuing operations attributable to Tivity Health, Inc.
 
 
$
19,208
 
 
$
19,962
 
 
$
4,799
 
 
$
12,125
 
Net income (loss) from discontinued operations attributable to Tivity Health, Inc.
  
$
(33,417
)
 
$
(195,558
) 
 
$
48,995
 
 
$
(5,225
) 
Net income (loss) attributable to Tivity Health, Inc.
  
$
(14,209
)
 
$
(175,596
) 
 
$
53,794
 
 
$
6,900
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Earnings (loss) per share attributable to Tivity Health, Inc. – basic:
                 
Continuing operations (1)
 
 
$
0.53
 
 
$
0.55
 
 
$
0.13
 
 
$
0.31
 
Discontinued operations (1)
 
 
$
(0.93
)
 
$
(5.41
) 
 
$
1.32
 
 
$
(0.14
) 
Net income (loss) (1) (2)
 
 
$
(0.39
)
 
$
(4.85
) 
 
$
1.45
 
 
$
0.18
 
                  
Earnings (loss) per share attributable to Tivity Health, Inc. – diluted:
                 
Continuing operations (1)
 
 
$
0.52
 
 
$
0.54
 
 
$
0.12
 
 
$
0.30
 
Discontinued operations (1)
 
 
$
(0.91
)
 
$
(5.25
) 
 
$
1.28
 
 
$
(0.13
)
Net income (loss) (1) (2)
 
 
$
(0.39
)
 
$
(4.72
) 
 
$
1.40
 
 
$
0.17
 
                  
(In thousands, except per share data)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Year Ended December 31, 2015
 
 
First
 
 
Second
 
 
Third
 
 
Fourth
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenues
 
 
$
111,649
 
 
$
113,425
 
 
$
113,536
 
 
$
113,482
 
Gross margin
 
 
$
30,146
 
 
$
34,711
 
 
$
33,078
 
 
$
30,748
 
Income before income taxes
 
 
$
17,775
 
 
$
17,698
 
 
$
21,383
 
 
$
16,063
 
Net income from continuing operations attributable to Tivity Health, Inc.
 
 
$
10,680
 
 
$
10,756
 
 
$
12,960
 
 
$
9,238
 
Net loss from discontinued operations attributable to Tivity Health, Inc.
  
$
(13,593
)
 
$
(10,336
) 
 
$
(21,986
) 
 
$
(28,666
) 
Net income (loss) attributable to Tivity Health, Inc.
  
$
(2,913
)
 
$
420
 
 
$
(9,026
) 
 
$
(19,428
) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Earnings (loss) per share attributable to Tivity Health, Inc. – basic:
                 
Continuing operations (1)
 
 
$
0.30
 
 
$
0.30
 
 
$
0.36
 
 
$
0.26
 
Discontinued operations (1)
 
 
$
(0.38
)
 
$
(0.29
) 
 
$
(0.61
) 
 
$
(0.79
) 
Net income (loss) (1) (2)
  
$
(0.08
)
 
$
0.01
 
 
$
(0.25
)
 
$
(0.54
)
                  
Earnings (loss) per share attributable to Tivity Health, Inc. – diluted:
                 
Continuing operations (1)
 
 
$
0.29
 
 
$
0.29
 
 
$
0.35
 
 
$
0.25
 
Discontinued operations (1)
 
 
$
(0.37
)
 
$
(0.28
) 
 
$
(0.60
) 
 
$
(0.78
)
Net income (loss) (1) (2)
  
$
(0.08
)
 
$
0.01
 
 
$
(0.25
)
 
$
(0.53
)


(1)
We calculated earnings per share for each of the quarters based on the weighted average number of shares and dilutive securities outstanding for each period. Accordingly, the sum of the quarters may not necessarily be equal to the full year income per share.

(2)
Figures may not add due to rounding.

(3)
Net income from continuing operations for the fourth quarter of 2016 includes the impact of a $2.2 million out of period adjustment to decrease depreciation expense included in continuing operations (with a corresponding increase to depreciation expense included in discontinued operations) related to the correction of our previous allocation of 2016 depreciation expense between continuing and discontinued operations based on having completed our asset separation analysis.  The previous interim periods in 2016 were not materially misstated, nor is the correction material to the interim results for the fourth quarter of 2016.